TY - JOUR AU - Jankovic, B. AU - Le, K. T. AU - Hershman, J. M. PY - 2013 DA - 2013// TI - Clinical review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation? JO - J Clin Endocrinol Metab VL - 98 UR - https://doi.org/10.1210/jc.2012-2978 DO - 10.1210/jc.2012-2978 ID - Jankovic2013 ER - TY - JOUR AU - Gamper, E. M. PY - 2015 DA - 2015// TI - Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3022-9 DO - 10.1007/s00259-015-3022-9 ID - Gamper2015 ER - TY - JOUR AU - Goffredo, P. PY - 2015 DA - 2015// TI - Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse JO - JAMA Intern Med VL - 175 UR - https://doi.org/10.1001/jamainternmed.2014.8020 DO - 10.1001/jamainternmed.2014.8020 ID - Goffredo2015 ER - TY - JOUR AU - Chou, R. H. AU - Yu, Y. L. AU - Hung, M. C. PY - 2011 DA - 2011// TI - The roles of EZH2 in cell lineage commitment JO - Am J Transl Res VL - 3 ID - Chou2011 ER - TY - JOUR AU - Song, X. PY - 2016 DA - 2016// TI - Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation JO - Biomed Pharmacother VL - 81 UR - https://doi.org/10.1016/j.biopha.2016.04.019 DO - 10.1016/j.biopha.2016.04.019 ID - Song2016 ER - TY - JOUR AU - Cao, R. PY - 2002 DA - 2002// TI - Role of histone H3 lysine 27 methylation in Polycomb-group silencing JO - Science VL - 298 UR - https://doi.org/10.1126/science.1076997 DO - 10.1126/science.1076997 ID - Cao2002 ER - TY - JOUR AU - Sauvageau, M. AU - Sauvageau, G. PY - 2010 DA - 2010// TI - Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer JO - Cell Stem Cell VL - 7 UR - https://doi.org/10.1016/j.stem.2010.08.002 DO - 10.1016/j.stem.2010.08.002 ID - Sauvageau2010 ER - TY - JOUR AU - Rizzo, S. PY - 2011 DA - 2011// TI - Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2 JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-10-0788 DO - 10.1158/1535-7163.MCT-10-0788 ID - Rizzo2011 ER - TY - JOUR AU - Wang, Y. PY - 2016 DA - 2016// TI - DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity JO - Cell Death Dis VL - 7 UR - https://doi.org/10.1038/cddis.2016.198 DO - 10.1038/cddis.2016.198 ID - Wang2016 ER - TY - JOUR AU - Collett, K. PY - 2006 DA - 2006// TI - Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1533 DO - 10.1158/1078-0432.CCR-05-1533 ID - Collett2006 ER - TY - JOUR AU - Behrens, C. PY - 2013 DA - 2013// TI - EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3946 DO - 10.1158/1078-0432.CCR-12-3946 ID - Behrens2013 ER - TY - JOUR AU - Varambally, S. PY - 2002 DA - 2002// TI - The polycomb group protein EZH2 is involved in progression of prostate cancer JO - Nature VL - 419 UR - https://doi.org/10.1038/nature01075 DO - 10.1038/nature01075 ID - Varambally2002 ER - TY - JOUR AU - Borbone, E. PY - 2011 DA - 2011// TI - Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas JO - J Clin Endocrinol Metab VL - 96 UR - https://doi.org/10.1210/jc.2010-1784 DO - 10.1210/jc.2010-1784 ID - Borbone2011 ER - TY - JOUR AU - Gonzalez, M. E. PY - 2014 DA - 2014// TI - EZH2 expands breast stem cells through activation of NOTCH1 signaling JO - Proc Natl Acad Sci U S A VL - 111 UR - https://doi.org/10.1073/pnas.1308953111 DO - 10.1073/pnas.1308953111 ID - Gonzalez2014 ER - TY - JOUR AU - Xu, K. PY - 2012 DA - 2012// TI - EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent JO - Science VL - 338 UR - https://doi.org/10.1126/science.1227604 DO - 10.1126/science.1227604 ID - Xu2012 ER - TY - JOUR AU - Xu, H. PY - 2011 DA - 2011// TI - Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0027399 DO - 10.1371/journal.pone.0027399 ID - Xu2011 ER - TY - JOUR AU - Kleer, C. G. PY - 2003 DA - 2003// TI - EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1933744100 DO - 10.1073/pnas.1933744100 ID - Kleer2003 ER - TY - JOUR AU - Al-Zahrani, A. S. AU - Ravichandran, K. PY - 2007 DA - 2007// TI - Epidemiology of thyroid cancer: a review with special reference to gulf cooperation council (GCC) states JO - Gulf J Oncolog VL - 2 ID - Al-Zahrani2007 ER - TY - STD TI - Blander, C.L., Estrogens and breast cancer. N Engl J Med, 2006. 354(15): p. 1647–1648; author reply 1647-8. ID - ref19 ER - TY - JOUR AU - Kinoshita, Y. PY - 2013 DA - 2013// TI - Estrogen receptor- and progesterone receptor-positive diffuse sclerosing variant of papillary thyroid carcinoma: a case report JO - Case Rep Oncol VL - 6 UR - https://doi.org/10.1159/000350784 DO - 10.1159/000350784 ID - Kinoshita2013 ER - TY - JOUR AU - Huang, Y. PY - 2014 DA - 2014// TI - Differential expression patterns and clinical significance of estrogen receptor-alpha and beta in papillary thyroid carcinoma JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-383 DO - 10.1186/1471-2407-14-383 ID - Huang2014 ER - TY - JOUR AU - Inoue, H. PY - 1993 DA - 1993// TI - Immunohistochemical study of estrogen receptor and estradiol on papillary thyroid carcinoma in young patients JO - J Surg Oncol VL - 53 UR - https://doi.org/10.1002/jso.2930530407 DO - 10.1002/jso.2930530407 ID - Inoue1993 ER - TY - JOUR AU - Bhan, A. PY - 2014 DA - 2014// TI - Histone methyltransferase EZH2 is transcriptionally induced by estradiol as well as estrogenic endocrine disruptors bisphenol-a and diethylstilbestrol JO - J Mol Biol VL - 426 UR - https://doi.org/10.1016/j.jmb.2014.07.025 DO - 10.1016/j.jmb.2014.07.025 ID - Bhan2014 ER - TY - JOUR AU - Huang, C. PY - 2015 DA - 2015// TI - miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor alpha JO - J Clin Endocrinol Metab VL - 100 UR - https://doi.org/10.1210/jc.2014-2883 DO - 10.1210/jc.2014-2883 ID - Huang2015 ER - TY - JOUR AU - Sander, S. PY - 2008 DA - 2008// TI - MYC stimulates EZH2 expression by repression of its negative regulator miR-26a JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2008-03-147645 DO - 10.1182/blood-2008-03-147645 ID - Sander2008 ER - TY - JOUR AU - Varambally, S. PY - 2008 DA - 2008// TI - Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer JO - Science VL - 322 UR - https://doi.org/10.1126/science.1165395 DO - 10.1126/science.1165395 ID - Varambally2008 ER - TY - JOUR AU - Cao, Q. PY - 2011 DA - 2011// TI - Coordinated regulation of polycomb group complexes through microRNAs in cancer JO - Cancer Cell VL - 20 UR - https://doi.org/10.1016/j.ccr.2011.06.016 DO - 10.1016/j.ccr.2011.06.016 ID - Cao2011 ER -